Zhongfa Zhang
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 4
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies 10
- SARS-CoV-2 and COVID-19 Research 6
- Obstetrics and Gynecology top 5%
- Modeling and Simulation top 5%
- Molecular Biology top 10%
- Renal and related cancers 6
- Epigenetics and DNA Methylation 5
-
- Renal cell carcinoma treatment 6
- Lung Cancer Treatments and Mutations 4
-
- Long-Term Effects of COVID-19 4
Zhongfa Zhang
53 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 127
- Cancer Research 427
- Infectious Diseases 472
- Obstetrics and Gynecology 136
- Modeling and Simulation 66
- Molecular Biology 951
Countries citing papers authored by Zhongfa Zhang
This map shows the geographic impact of Zhongfa Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongfa Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongfa Zhang more than expected).
Fields of papers citing papers by Zhongfa Zhang
This network shows the impact of papers produced by Zhongfa Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongfa Zhang. The network helps show where Zhongfa Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhongfa Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 8 | |
| 5 | 2021 | 2 | |
| 6 | 2021 | 41 | |
| 7 | 2020 | 253 | |
| 8 | 2020 | 64 | |
| 9 | 2018 | 7 | |
| 10 | 2017 | 2 | |
| 11 | 2016 | 4 | |
| 12 | 2013 | 76 | |
| 13 | 2013 | 28 | |
| 14 | 2012 | 45 | |
| 15 | 2011 | 31 | |
| 16 | 2008 | 29 | |
| 17 | 2008 | 179 | |
| 18 | 2008 | 79 | |
| 19 | 2008 | 3 | |
| 20 | Multiple Hypothesis Testing For Finite and Infinite Test | 2005 | 1 |
About Zhongfa Zhang
Zhongfa Zhang is a scholar working on Infectious Diseases, Cancer Research and Pulmonary and Respiratory Medicine, having authored 57 papers that have together received 2.0k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (10 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Renal cell carcinoma treatment (6 papers), Renal and related cancers (6 papers), Epigenetics and DNA Methylation (5 papers), Cancer Genomics and Diagnostics (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Long-Term Effects of COVID-19 (4 papers). The work is most often cited by research in Cancer Research (427 citations), Infectious Diseases (472 citations) and Obstetrics and Gynecology (136 citations). Zhongfa Zhang has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Bin Tean Teh, David Petillo, Kyle A. Furge, Ximing J. Yang, Liang Su, Xiang Ma, Xiaoguo Zhang, Richard J. Kahnoski, Aikseng Ooi and Wenjun Du. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, BMC Medical Genomics, PLoS Genetics and Acta Pharmacologica Sinica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.